Erratum: “Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast cancer: A randomized controlled trial” (Journal of Clinical Oncology (2018) DOI: 10.1200/JCO.2017.75.7526);Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast cancer: A randomized controlled trial

Journal of Clinical Oncology

Volumn 36, Issue 9, 2018, Pages 875-883

  Dieli Conwright, Christina M ^a   Courneya, Kerry S ^c   Demark Wahnefried, Wendy ^d   Sami, Nathalie ^a   Lee, Kyuwan ^a   Buchanan, Thomas A ^a   Spicer, Darcy V ^a   Tripathy, Debu ^e   Bernstein, Leslie ^b   Mortimer, Joanne E ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; INSULIN; LEPTIN; TUMOR MARKER;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY COMPOSITION; BODY MASS; BONE MASS; BREAST CANCER; CANCER SURVIVOR; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FOLLOW UP; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SARCOPENIC OBESITY; STATISTICAL ANALYSIS; BLOOD; BREAST TUMOR; EXERCISE; PATHOLOGY; PROCEDURES; SARCOPENIA; TREATMENT OUTCOME; TUMOR RECURRENCE;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; EXERCISE; FEMALE; HUMANS; METABOLIC SYNDROME; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBESITY; OVERWEIGHT; RESISTANCE TRAINING; SARCOPENIA; TREATMENT OUTCOME;

EID: 85044215748     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.20.00521     Document Type: Erratum

References (53)

1. de Haas EC, Oosting SF, Lefrandt JD, et al: The metabolic syndrome in cancer survivors. Lancet Oncol 11:193-203, 2010
2. Russo A, Autelitano M, Bisanti L: Metabolic syndrome and cancer risk. Eur J Cancer 44:293-297, 2008
3. Capasso I, Esposito E, Pentimalli F, et al: Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience. Cancer Biol Ther 10:1240-1243, 2010
4. Agnoli C, Berrino F, Abagnato CA, et al: Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case-control study. Nutr Metab Cardiovasc Dis 20:41-48, 2010
5. Pasanisi P, Berrino F, De Petris M, et al: Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236-238, 2006
6. Calip GS, Malone KE, Gralow JR, et al: Metabolic syndrome and outcomes following early-stage breast cancer. Breast Cancer Res Treat 148:363-377, 2014
7. Earnest CP, Johannsen NM, Swift DL, et al: Aerobic and strength training in concomitant metabolic syndrome and type 2 diabetes. Med Sci Sports Exerc 46:1293-1301, 2014
8. Campbell KL, Neil SE, Winters-Stone KM: Review of exercise studies in breast cancer survivors: Attention to principles of exercise training. Br J Sports Med 46:909-916, 2012
9. Winters-Stone KM, Dobek J, Bennett JA, et al: The effect of resistance training on muscle strength and physical function in older, postmenopausal breast cancer survivors: A randomized controlled trial. J Cancer Surviv 6:189-199, 2012
10. Dieli-Conwright CM, Mortimer JE, Schroeder ET, et al: Randomized controlled trial to evaluate the effects of combined progressive exercise on metabolic syndrome in breast cancer survivors: Rationale, design, and methods. BMC Cancer 14:238, 2014
11. Shen W, Punyanitya M, Chen J, et al: Waist circumference correlates with metabolic syndrome indicators better than percentage fat. Obesity (Silver Spring) 14:727-736, 2006
12. Klein S, Allison DB, Heymsfield SB, et al: Waist circumference and cardiometabolic risk: A consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr 85:1197-1202, 2007
13. Thomas GA, Alvarez-Reeves M, Lu L, et al: Effect of exercise on metabolic syndrome variables in breast cancer survivors. Int J Endocrinol 2013:168797, 2013
14. MacLean PS, Higgins JA, Wyatt HR, et al: Regular exercise attenuates the metabolic drive to regain weight after long-term weight loss. Am J Physiol Regul Integr Comp Physiol 297:R793-R802, 2009
15. Bateman LA, Slentz CA, Willis LH, et al: Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise-STRRIDE-AT/RT). Am J Cardiol 108:838-844, 2011
16. Johnson JL, Slentz CA, Houmard JA, et al: Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise). Am J Cardiol 100:1759-1766, 2007
17. Grundy SM, Brewer HB Jr, Cleeman JI, et al: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24:e13-e18, 2004
18. Bonora E, Targher G, Alberiche M, et al: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63, 2000
19. Baumgartner RN: Body composition in healthy aging. Ann N Y Acad Sci 904:437-448, 2000
20. Kriska AM, Knowler WC, LaPorte RE, et al: Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 13:401-411, 1990
21. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
22. Ebbeling CB, Ward A, Puleo EM, et al: Development of a single-stage submaximal treadmill walking test. Med Sci Sports Exerc 23:966-973, 1991
23. Brzycki M: Strength testing-Predicting a one-rep max from repetition-to-fatigue. J Phys Ed Rec Dance 64:88-90, 1993
24. Rock CL, Doyle C, Demark-Wahnefried W, et al: Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62:243-274, 2012
25. Schmitz KH, Courneya KS, Matthews C, et al: American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409-1426, 2010
26. Irwin ML, Tworoger SS, Yasui Y, et al: Influence of demographic, physiologic, and psychosocial variables on adherence to a yearlong moderate-intensity exercise trial in postmenopausal women. Prev Med 39: 1080-1086, 2004
27. Ligibel JA, Campbell N, Partridge A, et al: Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol 26:907-912, 2008
28. Irwin ML, McTiernan A, Bernstein L, et al: Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 14:2881-2888, 2005
29. Porto LA, Lora KJ, Soares JC, et al: Metabolic syndrome is an independent risk factor for breast cancer. Arch Gynecol Obstet 284:1271-1276, 2011
30. Dieli-Conwright CM, Wong L, Waliany S, et al: An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy. Cancer 122:2646-2653, 2016
31. Ervin RB: Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Rep 13:1-7, 2009
32. Nuri R, Kordi MR, Moghaddasi M, et al: Effect of combination exercise training on metabolic syndrome parameters in postmenopausal women with breast cancer. J Cancer Res Ther 8:238-242, 2012
33. Guinan E, Hussey J, Broderick JM, et al: The effect of aerobic exercise on metabolic and inflammatory markers in breast cancer survivors-A pilot study. Support Care Cancer 21:1983-1992, 2013
34. Courneya KS, Segal RJ, Gelmon K, et al: Predictors of supervised exercise adherence during breast cancer chemotherapy. Med Sci Sports Exerc 40:1180-1187, 2008
35. Arem H, Sorkin M, Cartmel B, et al: Exercise adherence in a randomized trial of exercise on aro-matase inhibitor arthralgias in breast cancer survivors: The Hormones and Physical Exercise (HOPE) study. J Cancer Surviv 10:654-662, 2016
36. Schmitz KH, Ahmed RL, Hannan PJ, et al: Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins. Cancer Epidemiol Biomarkers Prev 14:1672-1680, 2005
37. Bakker EA, Lee DC, Sui X, et al: Association of resistance exercise, independent of and combined with aerobic exercise, with the incidence of metabolic syndrome. Mayo Clin Proc 92:1214-1222, 2017
38. Fairey AS, Courneya KS, Field CJ, et al: Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: A randomized controlled trial. Cancer Epidemiol Biomarkers Prev 12:721-727, 2003
39. Ivy JL: Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sports Med 24: 321-336, 1997
40. Cuff DJ, Meneilly GS, Martin A, et al: Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care 26:2977-2982, 2003
41. Prado CM, Lieffers JR, McCargar LJ, et al: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol 9:629-635, 2008
42. Dutra MT, Avelar BP, Souza VC, et al: Relationship between sarcopenic obesity-related phenotypes and inflammatory markers in postmenopausal women. Clin Physiol Funct Imaging 37:205-210, 2017
43. Batsis JA, Mackenzie TA, Jones JD, et al: Sar-copenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey. Clin Nutr 35:1472-1483, 2016
44. Adams SC, Segal RJ, McKenzie DC, et al: Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: A multicenter randomized controlled trial. Breast Cancer Res Treat 158:497-507, 2016
45. Brown JC, Schmitz KH: Weight lifting and appendicular skeletal muscle mass among breast cancer survivors: A randomized controlled trial. Breast Cancer Res Treat 151:385-392, 2015
46. Harrigan M, Cartmel B, Loftfield E, et al: Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: The Lifestyle, Exercise, and Nutrition (LEAN) study. J Clin Oncol 34:669-676, 2016
47. Hursting SD: Obesity, energy balance, and cancer: A mechanistic perspective. Cancer Treat Res 159:21-33, 2014
48. Irwin ML: Weight loss interventions and breast cancer survival: The time is now. J Clin Oncol 32:2197-2199, 2014
49. Meneses-Echávez JF, Correa-Bautista JE, González-Jiménez E, et al: The effect of exercise training on mediators of inflammation in breast cancer survivors:Asystematicreviewwithmeta-analysis.Cancer Epidemiol Biomarkers Prev 25:1009-1017, 2016
50. Kang DW, Lee J, Suh SH, et al: Effects of exercise on insulin, IGF axis, adipocytokines, and inflammatory markers in breast cancer survivors: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 26:355-365, 2017
51. Goodwin PJ, Ennis M, Pritchard KI, et al: Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study. J Clin Oncol 20:42-51, 2002
52. Barone BB, Yeh HC, Snyder CF, et al: Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis. JAMA 300:2754-2764, 2008
53. Ligibel JA, Barry WT, Alfano C, et al: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): Study design. NPJ Breast Cancer 10.1038/s41523-017-0040-8 [epub ahead of print on September 21, 2017]